Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy
نویسندگان
چکیده
منابع مشابه
Seroprevalence of Feline Immunodeficiency Virus (FIV) among Client-owned Cats in Ahvaz, Southwestern of Iran
The present study was conducted to detect prevalence and risk factors for retrovirus infection of infected cats in a cat population in Iran, by evaluation of 238 client-owned cats of different ages that were tested for the presence of FIV antibodies. The cats were selected from those referring to Veterinary Hospital of Ahvaz University, southwestern Iran from December 2007 to June 2010. Classif...
متن کاملPlatelet Activation in Cats with Hypertrophic Cardiomyopathy
BACKGROUND Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. OBJECTIVES To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis ...
متن کاملDIFFUSE CORONARY ARTERIAL ECTASIA WITH HYPERTROPHIC CARDIOMYOPATHY
A 40 year old male, a known case of hypertrophic cardiomyopathy, was admitted for catheterization. At catheterization and angiography, septum was hypertrophied to about 5cm and diffuse coronary artery aneurysm was revealed. We found no previous report of coronary artery aneurysm in hypertrophic cardiomyopathy.
متن کاملThe embryological basis of subclinical hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomeric proteins, the commonest being MYBPC3 encoding myosin-binding protein C. It is characterised by left ventricular hypertrophy but there is an important pre-hypertrophic phenotype with features including crypts, abnormal mitral leaflets and trabeculae. We investigated these during mouse cardiac development using high-resolution...
متن کاملSymmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
BACKGROUND Symmetric dimethylarginine (SDMA) has been increasingly used as a marker of early chronic kidney disease (CKD) in cats, but little is known about the influence of comorbidities on SDMA in this species. HYPOTHESIS Hypertrophic cardiomyopathy (HCM) and diabetes mellitus (DM), independently of CKD, are associated with changes in serum SDMA. ANIMALS Ninety-four cats (17 with CKD, 40 ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Veterinary Research
سال: 2021
ISSN: 1746-6148
DOI: 10.1186/s12917-021-02799-9